Earnings per Share (EPS) (Basic): A company's net earnings or losses attributable to common shareholders per basic share basis.
Allena Pharmaceuticals, Inc. (ALNAQ) had Earnings per Share (EPS) (Basic) of $-0.72 for the most recently reported fiscal year, ending 2021-12-31.
| Income Statement Financials | |
-- |
|
$-48.66M |
|
-- |
|
-- |
|
$47.65M |
|
$-47.65M |
|
$-1.01M |
|
$-48.66M |
|
$-48.66M |
|
$-48.66M |
|
$-48.66M |
|
$-48.66M |
|
$-48.66M |
|
$-47.65M |
|
$-47.29M |
|
67.96M |
|
67.96M |
|
|
Earnings per Share (EPS) (Basic) |
$-0.72 |
$-0.72 |
|
| Balance Sheet Financials | |
$33.01M |
|
$1.17M |
|
$1.75M |
|
$34.76M |
|
$15.68M |
|
-- |
|
$0.21M |
|
$15.89M |
|
$18.87M |
|
$18.87M |
|
$18.87M |
|
82.97M |
|
| Cash Flow Statement Financials | |
$-45.68M |
|
$-0.67M |
|
$41.29M |
|
$35.04M |
|
$29.99M |
|
$-5.05M |
|
$3.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.11 |
|
-- |
|
-- |
|
-- |
|
0.52 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-46.34M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-257.91% |
|
-257.91% |
|
-140.01% |
|
-257.91% |
|
$0.23 |
|
$-0.68 |
|
$-0.67 |
|